EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures

Sjan Teeselink iD, Sanne C C Vincenten iD, Amir Chaman Baz iD, Nicol C Voermans iD, Nens van Alfen iD, Baziel G M van Engelen iD, Karlien Mul iD

Muscle & Nerve · 2026-12 · 74 (6) · 1663-1667

DOI: 10.1002/mus.70413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 19.10.2026. Verfasst von Sjan Teeselink und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Outcome Assessment, Health Care. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Prinses Beatrix Spierfonds, FSHD Stichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Identifying endpoints that are sensitive to change is crucial for clinical trial design in facioscapulohumeral muscular dystrophy (FSHD). This study adds follow‐up data to a previously published 5‐year natural history study in the same cohort, aiming to correlate short‐term disease progression to longer term follow‐up.

Methods

Adult FSHD patients were reassessed 1.5 years after their 5‐year visit. A subgroup underwent trimonthly assessments for 1 year following the 1.5‐year visit. Disease severity scores, motor function measure (MFM), 6‐min walk test (6MWT), antigravity tests (AGTs), and muscle strength by manual muscle testing (MMT) were assessed to determine change over time. Sample sizes were calculated for a hypothetical trial assuming stabilization of the disease as treatment aim.

Results

Eighty‐six patients completed both assessments, 30 of whom underwent trimonthly assessments. Over 1.5 years, a small decline was observed in the mean MMT score (median change: −0.2, p < 0.001), and the 6MWT (median change: −14 m, p = 0.009). In the trimonthly subgroup, individual mean MMT scores were variable between visits. Sample size estimates ranged from 16 (MMT of specific muscles) to 1824 participants (MFM) per group depending on the used clinical outcome measure and patient selection.

Discussion

This study provides clinically relevant data on short‐term progression in FSHD. The findings confirm the limited responsiveness of clinical outcome measures resulting in large sample size estimates, demonstrate variability of MMT, and highlight the need for multimodal or biomarker‐based endpoints to enable feasible and sensitive clinical trial design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralOutcome Assessment, Health CareHumansFemaleMaleFollow-Up StudiesMiddle AgedAdultMuscle StrengthCohort StudiesDisease ProgressionAgedSeverity of Illness IndexWalk Test

Stichwörter der Autor:innen

clinical outcome measuresclinical trial readinessfacioscapulohumeral muscular dystrophy

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.

ORCID-Profile: Sjan Teeselink, Sanne C C Vincenten, Amir Chaman Baz, Nicol C Voermans, Nens van Alfen, Baziel G M van Engelen, Karlien Mul

Förderung

  • Prinses Beatrix Spierfonds
  • FSHD Stichting

Zitieren

APA

Teeselink, S., Vincenten, S. C. C., Baz, A. C., Voermans, N. C., van Alfen, N., van Engelen, B. G. M., & Mul, K. (2026). From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures. Muscle & Nerve, 74(6), 1663-1667. https://doi.org/10.1002/mus.70413

Vancouver

Teeselink S, Vincenten SCC, Baz AC, Voermans NC, van Alfen N, van Engelen BGM, et al. From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures. Muscle & Nerve. 2026;74(6):1663-1667. doi:10.1002/mus.70413

BibTeX
@article{Teeselink2026,
  author = {Teeselink, Sjan and Vincenten, Sanne C C and Baz, Amir Chaman and Voermans, Nicol C and van Alfen, Nens and van Engelen, Baziel G M and Mul, Karlien},
  title = {From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {1663--1667},
  doi = {10.1002/mus.70413}
}
Kostenlos starten →